Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 154,682 | 62,103 | 45,540 | 112,672 | 112,765 |
| Marketable Securities | 218,437 | 264,277 | 267,281 | 187,594 | 122,922 |
| TOTAL | $394,173 | $348,700 | $332,897 | $321,218 | $250,149 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 5,108 | 18,793 |
| Other Non-Current Assets | 545 | 595 | 272 | 229 | 564 |
| TOTAL | $545 | $595 | $272 | $5,337 | $19,357 |
| Total Assets | $394,718 | $349,295 | $333,169 | $326,555 | $269,506 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,217 | 8,727 | 5,934 | 5,933 | 4,060 |
| Accrued Expenses | 25,309 | 16,169 | 19,997 | 15,569 | 15,478 |
| TOTAL | $27,844 | $24,995 | $25,945 | $21,558 | $19,636 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 33 | 320 | 0 | 0 | 0 |
| TOTAL | $33 | $320 | $N/A | $N/A | $N/A |
| Total Liabilities | $27,877 | $25,315 | $25,945 | $21,558 | $19,636 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,308 | 46,575 | 44,202 | 41,281 | 40,569 |
| Common Shares | 5 | 5 | 4 | 4 | 4 |
| Retained earnings | -497,854 | -447,961 | -404,641 | -369,097 | -334,119 |
| Other shareholders' equity | -267 | -270 | 14 | 206 | -18 |
| TOTAL | $366,841 | $323,980 | $307,224 | $304,997 | $249,870 |
| Total Liabilities And Equity | $394,718 | $349,295 | $333,169 | $326,555 | $269,506 |